首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Examination of sulfonamide-based inhibitors of MMP3 using the conditioned media of invasive glioma cells
【24h】

Examination of sulfonamide-based inhibitors of MMP3 using the conditioned media of invasive glioma cells

机译:使用侵袭性胶质瘤细胞调节培养基检查MMP3的磺酰胺基抑制剂

获取原文
           

摘要

Glioblastoma multiforme (GBM) is the deadliest and the most common primary malignant brain tumour. The median survival for patients with GBM is around one year due to the nature of glioma cells to diffusely invade that make the complete surgical resection of tumours difficult. Based upon the connexin43 (Cx43) model of glioma migration we have developed a computational framework to evaluate MMP inhibition in materials relevant to GBM. Using the ilomastat Leu-Trp backbone, we have synthesised novel sulphonamides and monitored the performance of these compounds in conditioned media expressing MMP3. From the results discussed herein we demonstrate the performance of sulfonamide based MMPIs included AP-3, AP-6, and AP-7.
机译:胶质母细胞瘤多形体(GBM)是最致命的和最常见的原发性恶性脑肿瘤。由于胶质瘤细胞的性质,GBM患者的中位数存活率为一年,因为胶质瘤细胞弥漫性侵入,使得完全外科切除肿瘤困难。基于Connexin43(CX43)胶质瘤迁移模型,我们开发了一种计算框架,以评估与GBM相关的材料中的MMP抑制。使用ILOMastat Leu-TRP骨架,我们合成了新的磺酰胺,并监测了表达MMP3的条件培养基中这些化合物的性能。根据本文所讨论的结果,我们证明了基于磺酰胺的MMPIS的性能AP-3,AP-6和AP-7。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号